 |
 |
 |
Pre-Congress Workshop by IMS Health
Pre-Congress Learning and Practice Workshop – IMS Health
Product Lifecycle & Portfolio Management: Strategies to Optimize Portfolio Results
• Best ways and practices to balance the needs of pre-launch, launch and mature products strategies
• Portfolio management: optimizing resource allocation between sales, marketing and strategic investments
• Testing strategic approaches in a competitive computer simulation exercise to drive change behaviour and improve effectiveness
Note: Only Platinum Passes have access to this Workshop.
There is also an only pre-congress pass available.
For more information about passes and prices, please visit the “Register now” website.
LifeCycle and Portfolio Management
UNIQUE DRUG STRATEGY INSIGHTS
Analyze the success of new product launches and speed of market penetration. |
|
Successful corporations know the importance of the whole lifecycle administration. Careful planning and management is a critical challenge and lifecycle management will help you apply modeling techniques to assess possible outcomes, and so better prepare you for every key stage in a brand’s lifecycle.
Speed of entry into the market can be a key determinant of drug success. As a result, more companies are using high-compression marketing strategies in their drug lunches. IMS LifeCycle provides insights on which companies are successful at launching products quickly, whether releasing a brand new chemical entity or the generic version of a drug that has lost patent protection.
PRODUCT LIFECYCLE : Critical stages
IMS LifeCycle combines three of the world’s most powerful pharmaceutical databases onto one platform, giving you a unique insight into drug strategies at 3 critical and defining stages of the drug lifecycle: R&D, launch activity and patent expiry.
IMS LifeCycle can be used to analyze, compare and measure competitive performance at each of these critical stages and help identify potential blockbusters, uncover commercial patent opportunities and evaluate success of launch strategies.
You can use IMS LifeCycle powerful database to help manage the drug lifecycle by:
Examining the market value and sales of leading companies and drugs by therapeutic area. |
ANALYTICS & EXPERTISE
Our approach combines analytical rigor and deep domain expertise to help clients generate strategic options and identify the most valuable. The result: the highest value strategy for your product and the ongoing ability to think beyond the molecule.
Our approach also helps avoid the common pitfalls that plague the execution of lifecycle management today, including:
|
ESSENTIAL INFORMATION
IMS LifeCycle will help you to track new product launches by country; review launch activity by indication and therapeutic area; analyze competitors’ historical and current launch strategies, verify generics penetration, monitor the entry of biotechnology drugs and identify New Chemical Entity launches each year.
Our end-to-end Lifecycle management capabilities offers you the confidence to make timely, smart decisions –that enhance efficiency, productivity and return on investment in sales and marketing.
It also gives you the insight to accelerate commercial launch success and maximize the lifetime value of a product or brand by reviewing market potential and forecast, creating effective launch plans and monitor uptake, optimizing sales force deployment and managing the overall lifecycle.
By integrating and analyzing market information, applying powerful analytics and infusing it with our industry knowledge, IMS LifeCycle provides you the intelligence to plan, build and tune portfolios for maximum success – setting the course for the future.
|
Global Sponsor |
 |
Platinum Sponsor |
 |
Workshop Sponsor |
 |
Supporting Sponsors |
 |
 |
Exhibitors |
 |
 |
 |
 |
Media Partners |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |